This Circular advises community pharmacy contractors of a new Universal Claim Framework (UCF) module that will be available for use by providers of Pharmacy First Plus from 1 February 2025.

This Circular advises community pharmacy contractors that the Serious Shortage Protocol for isosorbide mononitrate (Monomax® XL) 60mg modified release tablet due to expire on 18 October 2024 has been extended until Friday 15 November 2024. 

This Circular advises community pharmacy contractors of an updated Patient Group Direction (PGD) that is to be implemented for the provision of desogestrel as bridging contraception.

This Circular advises community pharmacy contractors of changes to NHS prescription stationery for the CP4/3 prescription form.

This circular sets out to community pharmacy contractors the details of the community pharmacy funding arrangement for 2024/25.

To advise of a Serious Shortage Protocol (SSP) in place for isosorbide mononitrate (Chemydur® 60XL) modified release tablet, from 6 September 2024 to 27 September 2024. 

This Circular advises contractors of a balancing payment relating to the 2023/24 global sum, which will be made along with September’s payments.

To advise of a Serious Shortage Protocol (SSP) in place for cefalexin 500mg tablets, from 6 August 2024 to 27 September 2024.

To advise of a Serious Shortage Protocol (SSP) in place for ramipril 2.5mg tablets, from 6 August 2024 to 15 November 2024.

The Scottish Government have released Circulars PCA(2024)12 through to 20 advising of Serious Shortage Protocols (SSPs) that are in place in relation to supply issues with Quetiapine 150mg, 200mg and 300mg tablets.

This Circular advises community pharmacy contractors that the two UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin antibiotic products due to expire on 21 June 2024 have now been extended until Friday 19 July 2024.

This Circular advises Health Boards and community pharmacy contractors that a series of Public Health Service (PHS) poster campaigns is planned to be distributed to pharmacies over the course of 2024/25

This Circular advises Health Boards and community pharmacy contractors that the two UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin 125mg/5ml and 250mg/5ml oral suspension have been reactivated on 22 May 2024. The new end date for both SSPs is now 21 June 2024.

To advise of a Serious Shortage Protocol (SSP) in place for Creon® 25000 gastro-resistant capsules, from 24 May 2024 to 22 November 2024.

To advise of a Serious Shortage Protocol (SSP) in place for Creon® 10000 gastro-resistant capsules, from 24 May 2024 to 22 November 2024.

This circular advises community pharmacy contractors and NHS Boards on the amendments to the Drug Tariff Part 11 clawback scale.

This Circular advises NHS Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for isosorbide mononitrate (Monomil® XL) 60mg modified release tablet due to expire on 3 May 2024 has been extended until Friday 31 May 2024.

This Circular encloses new guidance for dispensing General Practises across Scotland. 

To advise of a Serious Shortage Protocol (SSP) in place for isosorbide mononitrate (Monomil® XL) 60mg modified release tablet, from 26 March 2024 to 3 May 2024.

This Circular advises Health Boards and community pharmacy contractors of updated Patient Group Directions (PGDs) that are to be implemented for the treatment of shingles and skin infections under NHS Pharmacy First Scotland.

This Circular advises NHS Boards and healthcare professionals that print copies of the British National Formulary (BNF) and BNF for Children (BNFC) will no longer be provided

PCA(P)(2023)46 - Pharmaceutical Services Amendments To The Drug Tariff Part 11 Discount Clawback Scale

This Circular provides updated guidance aimed at both community optometry and community pharmacy teams and an updated referral form for the assessment and treatment of minor eye conditions.

This circular advises community pharmacy contractors and Health Boards of a corrective payment in order to deliver contractual requirements for the financial year 2023/24.

This Circular advises NHS Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for Clarithromycin

This circular informs NHS Boards and community pharmacy contractors of the intention to continue funding for Community Pharmacist Practitioner Champions in 2023-24.

This Circular advises NHS Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for Clarithromycin

This Circular advises NHS Boards and community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Estradot®

This Circular advises NHS Boards and community pharmacy contractors of the next Public Health Service (PHS) poster campaign topics which will be distributed to pharmacies.

This Circular advises NHS Boards and community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Jext® 300 micrograms/ 0.3mL (1 in 1000) solution for injection auto-injector pen